Myotonic dystrophy type 1 in South Korea: a comprehensive analysis of cancer and comorbidity risks
Neurological Sciences · 2024-09 · 45 (9) · 4573-4581
DOI: 10.1007/s10072-024-07527-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurological Sciences, online erschienen am 13.04.2024. Verfasst von Incheol Seo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea. Hauptthemen laut MEDLINE: Myotonic Dystrophy, Neoplasms, Comorbidity, Cataract. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
- Department of Neurology, Dongguk University Gyeongju Hospital, Dongguk University College of Medicine, Gyeongju, Republic of Korea. neuropjm@gmail.com.
Zitieren
APA
Seo, I., & Park, J. M. (2024). Myotonic dystrophy type 1 in South Korea: a comprehensive analysis of cancer and comorbidity risks. Neurological Sciences, 45(9), 4573-4581. https://doi.org/10.1007/s10072-024-07527-3
Vancouver
Seo I, Park JM. Myotonic dystrophy type 1 in South Korea: a comprehensive analysis of cancer and comorbidity risks. Neurological Sciences. 2024;45(9):4573-4581. doi:10.1007/s10072-024-07527-3
BibTeX
@article{Seo2024,
author = {Seo, Incheol and Park, Jin-Mo},
title = {Myotonic dystrophy type 1 in South Korea: a comprehensive analysis of cancer and comorbidity risks},
journal = {Neurological Sciences},
year = {2024},
volume = {45},
number = {9},
pages = {4573--4581},
doi = {10.1007/s10072-024-07527-3}
}
EUVIMED